According to a new market report published by Transparency Market Research, the global life science analytics market is expected to reach a value of US$ 39,200.9 Mn by 2026 on account of a large volume of data generated across the life science industry and rise in software usage to derive value from large volumes of structured, unstructured, and semi-structured data. The market is projected to expand at a CAGR of 12.0% during the forecast period from 2018 to 2026, driven by the increasing adoption of data management and data analytics solutions in the life science industry. Spending in the life science industry is anticipated to increase over the forecast period, driving digitization across the industry using software and related services. North America is anticipated to be a dominant region of the life science analytics market, followed by Asia Pacific, during the forecast period. In terms of end-user, the laboratory and pharmaceutical company segment is expected to expand at a rapid pace over the forecast period. Further, the use of analytics solutions, mainly for pharmaceutical data, customer data, lab results, and regulatory data, drives the life science analytics market.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23735
Turning Data into Intelligence is Driving the Global Life Science Analytics Market
Predictive and prescriptive analytics are approaches that help biomedical, medical device, and pharmaceutical companies in minimizing expenses and increasing productivity by turning data into valuable assets. Real-time data analysis is essential for deriving insights from unstructured data. The creation and consumption of data continues to rise, and with it, the investment in software, services, and data science. The availability of large amounts of data has led to technological innovation in analytics solutions. Data analytics tools have made the integration of genomic and clinical data easier, which can help manufacturers develop advanced personalized medicines. Rapidly changing and increasingly complex regulatory requirements become a critical risk to the life science sector. Analytics is helping companies in accurate regulatory reporting. The increasing volume of data generated in the life science industry and need to generate value from this data are driving the life science analytics market.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=23735
Life Science Analytics Market: Scope of the Report
The life science analytics market has been segmented based on type, component, application, end-user, and geography. In terms of application, the research and development segment is expected to account for more than 29% share of the global life science analytics market in 2026, due to an increase in IT spending in the R&D sector of the life science industry. The laboratory and pharmaceutical companies segment is anticipated to constitute more than 36% share in the life science analytics market in 2026, due to an increase in spending by laboratory and pharmaceutical companies and increasing analytics requirement across diverse applications in laboratory and pharmaceutical companies globally. The prescriptive analytics segment accounted for a key share in 2017, primarily driven by a rise in the use of prescriptive analytics for the purpose of illustrating the implication of each decision and providing insights into early stage drug development, marketing, and strategic planning.
North America leads the life science analytics market with a 45% share. This is due to increasing spending and technological advancements in the life science industry in the region. The U.S is a leading country of the life science analytics market, accounting for 86% share of the market in North America. Asia Pacific is expected to offer attractive expansion opportunities to the market in the coming years. Increasing adoption of advance technological solutions in the life science industry across China, Japan, and India is expected to offer prominent opportunities to the market.
Buy Life Science Analytics Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=23735<ype=S
Global Life Science Analytics Market: Competitive Dynamics
The research study includes profiles of leading companies operating in the global life science analytics market. Accenture PLC, SAS Institute, Inc., IBM Corporation, MaxisIT, Inc., Oracle Corporation, Wipro Limited, Cognizant Technology Solutions Corporation, SAP SE, Take Solutions, Inc., IQVIA (Quintiles, Inc.), and SCIOInspire, Corp. (Scio Health Analytics) are some of the key players that have been profiled in this study. Details such as company overview, financials, business strategies, and other such strategic information pertaining to these players have been provided as part of company profiling.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
